This may be of use to those trying to understand what lies ahead for PRR to eventually commercialise CVac.
Most contributors to this forum are aware of the therapeutic synergies between PRR and Dendreon (DNDN.
For those interested in the path DNDN is following to commercialise Provenge, Dendreons JP Morgan Conference presentation and the Q and A session are available in archived audio webcast on the DNDN website.
http://investor.dendreon.com/eventdetail.cfm?EventID=91079
Some of it is a little scientific but the presentation in particular gives a pretty good explanation of the steps they are taking and probable costs, both in the US and European Union.
The DNDN CEO says it has been a "15 year journey and billion dollar investment".
PRR are going to need some backers with deep pockets!
...........................................................
Apologies if this has already been posted.
We all have our own opinions and biases. You've just read mine!
prr v dndn, page-9
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |